Friday, March 23, 2018

Attacking lymphoma at the source

The efficacy of target specific therapies in lymphoma is limited to subgroups of patients. Scientists have identified a mechanism that confers resistance against a common therapy for lymphoma. They propose an alternative treatment that targets lymphoma signaling at its root, and show that it can be effective in a broader group of patients.

from Top Health News -- ScienceDaily http://ift.tt/2HZ7ttM

No comments:

Post a Comment

New fentanyl vaccine blocks deadly overdoses before they start

A new experimental vaccine developed by Scripps Research could offer a powerful new way to prevent fentanyl overdoses by stopping the drug b...